| CML | carboxymethyl lysine; cell-mediated lymphocytotoxicity; cell-mediated lympholysis; central motor lat... |
|---|---|
| CMSS | circulation, motor ability, sensation, and swelling; Council of Medical Specialty Societies |
| CMT | California mastitis test; cancer multistep therapy; catechol methyltransferase; certified medical tr... |
| CMUA | continuous motor unit activity |
| CRAMS | circulation, respiration, abdomen, motor, speech |
| somatoform disorders | Disorders having the presence of physical symptoms that suggest a general medical condition and that are not fully explained by a general medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to factitious disorders and malingering, the physical symptoms are not under voluntary control. (12 Dec 1998) |
|---|---|
| speech disorders | Long-term disorders in speaking or in perception of speech. (12 Dec 1998) |
| necrobiotic disorders | A group of disorders characterised by swelling, basophilia, and distortion of collagen bundles in the dermis. (12 Dec 1998) |
| neurotic disorders | Disorders in which the symptoms are distressing to the individual and recognised by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment. (12 Dec 1998) |
| stress disorders, posttraumatic | Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event and numbing of responsiveness to or reduced involvement with the external world. (12 Dec 1998) |
| substance abuse disorders | A class of mental disorders in which behavioural and biological changes are associated with regular use of alcohol, drugs, and related substances that affect the central nervous system and personal and social functioning. (05 Mar 2000) |
| substance-induced organic mental disorders | Mental disorders caused by use of drugs, e.g., cocaine. (05 Mar 2000) |
| substance-related disorders | These non-psychotic disorders include those related to the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure. (12 Dec 1998) |
| delirium, dementia, amnestic, cognitive disorders | Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes. (12 Dec 1998) |
| disorders, myeloproliferative | Tumours of certain bone marrow cells including those that give rise to red cells, granulocytes, and platelets. As opposed to the lymphoproliferative disorders. (12 Dec 1998) |
| dissociative disorders | Sudden temporary alterations in the normally integrative functions of consciousness. (12 Dec 1998) |
| immunodeficiency disorders | <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy (12 Dec 1998) |
| immunoproliferative disorders | Disorders characterised by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins. (12 Dec 1998) |
| impulse control disorders | Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act. (12 Dec 1998) |
| infant nutrition disorders | Malnutrition, occurring in infants ages 1 month to 24 months, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected. (12 Dec 1998) |